CoA-LOT: BN20240403/CA
In 2025 the first blood test for Alzheimer's disease, the Lumipulse G pTau217/Amyloid 142 Plasma Ratio, was cleared by the U.S Food and Drug Administration (FDA)
Full mechanism, beta-3 AR pathway detail, and research design guidance are available in the AOD-9604 5mg research guide on the Ascend Peptides UK blog
If implemented, this would re-legalize BPC-157, Thymosin Alpha-1, AOD-9604, Semax, Selank, KPV, and MOTS-c for compounding with a prescription
Research Grade FoundationChemical Characteristics:Combination of regenerative peptides
Someone treating active hair loss needs more than someone maintaining already healthy hair